J C Montero
Overview
Explore the profile of J C Montero including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
454
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Levis C, Costa F, Bongers F, Pena-Claros M, Clement C, Junqueira A, et al.
Science
. 2017 Mar;
355(6328):925-931.
PMID: 28254935
The extent to which pre-Columbian societies altered Amazonian landscapes is hotly debated. We performed a basin-wide analysis of pre-Columbian impacts on Amazonian forests by overlaying known archaeological sites in Amazonia...
2.
Seoane S, Montero J, Ocana A, Pandiella A
Oncogene
. 2015 Sep;
35(21):2756-65.
PMID: 26364598
Advances in the treatment of breast cancer have resulted in increased survival. However, in the metastatic setting, the disease remains incurable. Therefore, understanding of the mechanisms that promote dissemination of...
3.
Ocio E, Fernandez-Lazaro D, San-Segundo L, Lopez-Corral L, Corchete L, Gutierrez N, et al.
Leukemia
. 2014 Aug;
29(3):705-14.
PMID: 25102946
The development of resistance to therapy is unavoidable in the history of multiple myeloma patients. Therefore, the study of its characteristics and mechanisms is critical in the search for novel...
4.
Montero J, Esparis-Ogando A, Re-Louhau M, Seoane S, Abad M, Calero R, et al.
Oncogene
. 2012 Dec;
33(2):148-56.
PMID: 23246963
Triple-negative breast cancer (TNBC) is an aggressive form of breast cancer. Despite response to chemotherapy, relapses are frequent and resistance to available treatments is often seen in the metastatic setting....
5.
Valcarcel Y, Alonso S, Rodriguez-Gil J, Castano A, Montero J, Criado-Alvarez J, et al.
Environ Sci Pollut Res Int
. 2012 Aug;
20(3):1396-412.
PMID: 22847337
Numerous studies have shown the presence of pharmaceutically active compounds (PhACs) in different environmental compartments, for example, in surface water or wastewater ranging from nanograms per litre to micrograms per...
6.
Montero J, Miron I, Criado-Alvarez J, Linares C, Diaz J
Sci Total Environ
. 2011 Dec;
414:73-80.
PMID: 22154213
Introduction: All the climate-change studies undertaken to date agree that one of the principal consequences of this phenomenon is the increase in heat waves, which, without exception, are linked to...
7.
Alonso S, Valcarcel Y, Montero J, Catala M
Sci Total Environ
. 2011 Dec;
416:527-31.
PMID: 22137651
The presence of pharmaceuticals in surface and drinking water has been evidenced in numerous studies. Despite representing one of the most common consumption sources, to the best of our knowledge,...
8.
Montero J, Seoane S, Ocana A, Pandiella A
Oncogene
. 2010 Nov;
30(9):1059-71.
PMID: 21042280
The Neuregulins and their receptors, the ErbB/HER subfamily of receptor tyrosine kinases, have critical roles in animal physiology, and their deregulation is frequent in cancer. Here we report the identification...
9.
Montero J, Miron I, Criado-Alvarez J, Linares C, Diaz J
Sci Total Environ
. 2010 Sep;
408(23):5768-74.
PMID: 20833411
Introduction: As is known, the effects of extreme temperatures on mortality are characterised by an annual periodicity, with a rise centred in the winter months. The most recent epidemiological studies...
10.
Noe G, Sitruk-Ware R, Zegers-Hochschild F, Variano B, Montero J, Arriagada P, et al.
Climacteric
. 2010 Jul;
13(5):433-41.
PMID: 20642326
Aim: The type of estrogen and progestin as well as their doses, route and regimens of administration may each affect the benefit-risk profile of postmenopausal hormone therapy. The aim of...